HCA Healthcare (HCA) Projected to Post Quarterly Earnings on Tuesday

HCA Healthcare (NYSE:HCA) is expected to be releasing its Q3 2026 results before the market opens on Tuesday, October 27th. Analysts expect the company to post earnings of $6.65 per share and revenue of $19.33 billion for the quarter. Individuals may visit the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Tuesday, October 27, 2026 at 10:00 AM ET.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. The firm had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%. The company’s revenue was up 8.7% on a year-over-year basis. During the same period last year, the company earned $6.84 earnings per share. On average, analysts expect HCA Healthcare to post $29.51 EPS for the current fiscal year and $32.04 EPS for the next fiscal year.

HCA Healthcare Trading Up 0.5%

Shares of NYSE:HCA opened at $469.45 on Friday. HCA Healthcare has a 1-year low of $353.99 and a 1-year high of $556.52. The stock has a market capitalization of $101.64 billion, a P/E ratio of 15.72, a P/E/G ratio of 1.58 and a beta of 1.10. The business has a 50-day moving average price of $431.58 and a two-hundred day moving average price of $418.97.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Attractive valuation: Zacks identifies HCA as a strong value stock, which may appeal to investors seeking a relatively inexpensive healthcare company with potential for market-beating returns. Here’s Why HCA Healthcare Is a Strong Value Stock
• Positive Sentiment: Defensive investor interest: A broader rotation toward high-quality, defensive companies in healthcare and other essential sectors could provide a supportive backdrop for HCA stock. Defensive Rotation Toward Quality Companies
• Positive Sentiment: Expansion in Florida: Cape Coral approved $31 million in incentives for a planned $300 million HCA hospital, supporting the company’s long-term market expansion and future capacity. Cape Coral Approves Incentives for HCA Hospital
• Neutral Sentiment: Upcoming earnings catalyst: HCA is scheduled to report third-quarter results around October 27. Investors are focused on admissions, occupancy, inpatient revenue and other operating metrics, with the report likely to determine the stock’s next significant move. HCA Third-Quarter Earnings Preview
• Neutral Sentiment: Workforce investment: HCA opened a clinical training center in Gainesville, which may strengthen its healthcare staffing pipeline but is unlikely to materially affect near-term earnings. HCA Opens Clinical Training Center
• Negative Sentiment: Mixed earnings outlook: Higher admissions, occupancy and inpatient revenue could help third-quarter results, but rising costs and fewer outpatient surgeries may pressure margins and temper investor expectations. Will HCA Earnings Benefit From Higher Admissions?

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on HCA. Weiss Ratings raised shares of HCA Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. Truist Financial dropped their target price on shares of HCA Healthcare from $535.00 to $495.00 and set a “buy” rating for the company in a research report on Monday, July 27th. Barclays cut their target price on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating on the stock in a research note on Monday, July 27th. Deutsche Bank Aktiengesellschaft set a $476.00 price target on HCA Healthcare in a research note on Monday, July 27th. Finally, Wells Fargo & Company lifted their price objective on shares of HCA Healthcare from $369.00 to $381.00 and gave the stock an “equal weight” rating in a research note on Monday, August 3rd. Sixteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $467.61.

About HCA Healthcare

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.